Novo Nordisk A/S - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US6701002056

SecurityNVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionGrimes & Company, Inc.
Latest Disclosed Ownership105,108 shares
Latest Disclosed Value $ 3,862,725
Grimes & Company, Inc. reports 5.51% increase in ownership of NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 21, 2026 - Grimes & Company, Inc. filed a 13F-HR form disclosing ownership of 105,108 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (US:NVO) valued at $3,862,719 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 99,620 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 5.51% during the quarter. The current value of the position is $4,414,536 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 105,108 5,488 5.51 3,863 -23.80 0.0888
2026-02-03 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 99,620 -14,132 -12.42 5,069 -19.71 0.1211
2025-10-27 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 113,752 -11,604 -9.26 6,312 -27.05 0.1559
2025-07-22 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 125,356 18,403 17.21 8,652 16.51 0.2354
2025-04-17 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 106,953 3,273 3.16 7,427 -16.73 0.2296
2025-01-21 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 103,680 -2,261 -2.13 8,919 -29.30 0.2569
2024-10-22 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 105,941 -1,300 -1.21 12,614 -17.59 0.3413
2024-07-22 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 107,241 1,557 1.47 15,308 12.81 0.4581
2024-04-17 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 105,684 2,914 2.84 13,570 27.64 0.4172
2024-01-24 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 102,770 1,889 1.87 10,632 15.88 0.3520
2023-10-19 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 100,881 47,395 88.61 9,174 6.00 0.3548
2023-07-19 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 53,486 250 0.47 8,656 2.17 0.3069
2023-04-20 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 53,236 -26,426 -33.17 8,472 -21.43 0.3472
2023-01-25 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 79,662 1,170 1.49 10,781 37.86 0.4551
2022-10-28 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 78,492 -1,553 -1.94 7,820 -12.32 0.4081
2022-07-22 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 80,045 -29,925 -27.21 8,919 -26.97 0.4497
2022-05-06 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 109,970 -67,853 -38.16 12,212 -38.68 0.5704
2022-02-01 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 177,823 -624 -0.35 19,916 16.24 0.9116
2021-11-08 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 178,447 -3,712 -2.04 17,133 12.28 0.7455
2021-08-04 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 182,159 714 0.39 15,259 24.74 0.6621
2021-05-12 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 181,445 20,418 12.68 12,233 8.76 0.5883
2021-02-02 2020-12-31 13F Novo Nordisk A COM 670100205 161,027 7,901 5.16 11,248 5.79 0.5844
2020-11-12 2020-09-30 13F Novo Nordisk A COM 670100205 153,126 -45,350 -22.85 10,632 -18.19 0.6800
2020-07-31 2020-06-30 13F Novo Nordisk A COM 670100205 198,476 -4,449 -2.19 12,996 6.39 0.9030
2020-05-05 2020-03-31 13F Novo Nordisk A COM 670100205 202,925 -6,182 -2.96 12,216 0.93 1.1150
2020-02-05 2019-12-31 13F Novo Nordisk A COM 670100205 209,107 -4,843 -2.26 12,103 9.42 0.7929
2019-11-05 2019-09-30 13F Novo Nordisk A COM 670100205 213,950 1,585 0.75 11,061 2.05 0.7880
2019-07-30 2019-06-30 13F Novo Nordisk A COM 670100205 212,365 2,713 1.29 10,839 -1.17 0.8226
2019-05-02 2019-03-31 13F Novo Nordisk A COM 670100205 209,652 4,408 2.15 10,967 15.98 0.8596
2019-02-01 2018-12-31 13F Novo Nordisk A COM 670100205 205,244 563 0.28 9,456 -2.00 0.9229
2018-11-09 2018-09-30 13F Novo Nordisk A COM 670100205 204,681 8,120 4.13 9,649 6.44 0.7725
2018-08-10 2018-06-30 13F Novo Nordisk A COM 670100205 196,561 -1,987 -1.00 9,065 -7.29 0.8012
2018-05-07 2018-03-31 13F Novo Nordisk A COM 670100205 198,548 -153 -0.08 9,778 -8.31 0.9474
2018-02-05 2017-12-31 13F Novo Nordisk A COM 670100205 198,701 -4,085 -2.01 10,664 9.22 1.0293
2017-11-03 2017-09-30 13F Novo Nordisk A COM 670100205 202,786 -3,180 -1.54 9,764 10.53 1.0382
2017-07-18 2017-06-30 13F Novo Nordisk A COM 670100205 205,966 -20,328 -8.98 8,834 13.88 0.9855
2017-05-01 2017-03-31 13F Novo Nordisk A COM 670100205 226,294 132,049 140.11 7,757 129.50 0.8497
2017-01-24 2016-12-31 13F Novo Nordisk A COM 670100205 94,245 -98,117 -51.01 3,380 -57.75 0.3920
2016-10-24 2016-09-30 13F Novo Nordisk A COM 670100205 192,362 192,362 0.00 8,000 1.0707
2016-07-25 2016-06-30 13F Novo Nordisk A COM 670100205 0 -4,371 -100.00 0 -100.00
2016-04-25 2016-03-31 13F Novo Nordisk A COM 670100205 4,371 0 0.00 237 -6.69 0.0305
2016-02-03 2015-12-31 13F Novo Nordisk A COM 670100205 4,371 -71 -1.60 254 5.39 0.0343
2015-10-08 2015-09-30 13F Novo Nordisk A COM 670100205 4,442 -2,779 -38.48 241 -38.99 0.0310
2015-08-11 2015-06-30 13F Novo Nordisk A COM 670100205 7,221 -165,259 -95.81 395 -95.71 0.0556
2015-04-24 2015-03-31 13F Novo Nordisk A COM 670100205 172,480 10,043 6.18 9,209 33.97 2.2136
2015-02-12 2014-12-31 13F Novo Nordisk A COM 670100205 162,437 574 0.35 6,874 -10.82 1.7768
2014-11-06 2014-09-30 13F Novo Nordisk A COM 670100205 161,863 550 0.34 7,708 3.45 2.0174
2014-07-28 2014-06-30 13F Novo Nordisk A COM 670100205 161,313 4,333 2.76 7,451 3.98 1.9522
2014-05-01 2014-03-31 13F Novo Nordisk A COM 670100205 156,980 125,534 399.20 7,166 23.34 2.0126
2014-02-03 2013-12-31 13F Novo Nordisk A COM 670100205 31,446 3,205 11.35 5,810 21.57 1.7363
2013-10-29 2013-09-30 13F Novo Nordisk A COM 670100205 28,241 3,278 13.13 4,779 23.52 1.6165
2013-07-30 2013-06-30 13F Novo Nordisk A COM 670100205 24,963 24,963 3,869 1.4110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.